Anteotech Ltd (AnteoTech), formerly Anteo Diagnostics Limited, is a medical technology company that develops and commercializes healthcare products. The company along with its subsidiaries is a provider of Immunoassays, In-vitro Diagnostics, and Point of Care (PoC) tests to entities involved in the life sciences, bio-separation, and medical device markets. The company's major offerings include AnteoCoat, AnteoX, AnteoBind and AnteoRelease. AnteoTech also develops technologies for developing lithium-ion batteries. It uses its surface management technology for the development of its products. AnteoTech is headquartered in Brisbane, Queensland, Australia.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Anteotech Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Anteotech Ltd Company Overview
- Anteotech Ltd Company Snapshot
- Anteotech Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Anteotech Ltd - Pipeline Analysis Overview
- Business Description
- Anteotech Ltd - Key Facts
- Anteotech Ltd - Major Products and Services
- Anteotech Ltd Pipeline Products by Development Stage
- Anteotech Ltd Ongoing Clinical Trials by Trial Status
- Anteotech Ltd Pipeline Products Overview
- AtomoRapid - Heart Attack
- AtomoRapid - Heart Attack Product Overview
- COVID-19 Antigen Flu A Flu B Multiplex RDT
- COVID-19 Antigen Flu A Flu B Multiplex RDT Product Overview
- COVID-19 Flu A/ Flu B Multiplex Test
- COVID-19 Flu A/ Flu B Multiplex Test Product Overview
- COVID-19 High Sensitivity Antigen Rapid Test
- COVID-19 High Sensitivity Antigen Rapid Test Product Overview
- COVID-19 Saliva Test
- COVID-19 Saliva Test Product Overview
- EuGeni COVID-19 Saliva Test
- EuGeni COVID-19 Saliva Test Product Overview
- EuGeni Rapid Diagnostic System
- EuGeni Rapid Diagnostic System Product Overview
- Point Of Care Tropical Disease Assay
- Point Of Care Tropical Disease Assay Product Overview
- Point-Of-Care Bone Metabolism Assay
- Point-Of-Care Bone Metabolism Assay Product Overview
- Point-of-Care Infectious Disease Assay
- Point-of-Care Infectious Disease Assay Product Overview
- SARS-CoV-2 Ag Rapid Diagnostic Test (RDT)
- SARS-CoV-2 Ag Rapid Diagnostic Test (RDT) Product Overview
- SARS-CoV-2 Ag Rapid Diagnostic Test (RDT) Clinical Trial
- Sepsis Diagnostic Test
- Sepsis Diagnostic Test Product Overview
- Sepsis Multiplex RDT
- Sepsis Multiplex RDT Product Overview
- Anteotech Ltd - Key Competitors
- Anteotech Ltd - Key Employees
- Anteotech Ltd - Key Employee Biographies
- Anteotech Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Anteotech Ltd, Recent Developments
- Nov 02, 2022: European RAT clinical trial halted to refocus initiatives
- Oct 31, 2022: AnteoTech strengthens management team to accelerate commercial development
- May 18, 2022: Updated COVID-19 RAT receives regulatory approval in Europe
- Feb 09, 2022: AnteoTech: TGA registration update (3)
- Dec 15, 2021: AnteoTech: TGA registration update
- Sep 23, 2021: Therapeutic goods administration registration submitted
- Sep 23, 2021: AnteoTech signs Romanian distribution agreement for EuGeni
- Sep 16, 2021: AnteoTech secures EuGeni distribution agreement for Greece and Cyprus
- Sep 06, 2021: AnteoTech signs Turkish distribution agreement for EuGeni
- Aug 06, 2021: AnteoTech signs Philippines distribution agreement for EuGeni
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Anteotech Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Anteotech Ltd Pipeline Products by Equipment Type
- Anteotech Ltd Pipeline Products by Indication
- Anteotech Ltd Ongoing Clinical Trials by Trial Status
- Anteotech Ltd, Key Facts
- Anteotech Ltd, Major Products and Services
- Anteotech Ltd Number of Pipeline Products by Development Stage
- Anteotech Ltd Pipeline Products Summary by Development Stage
- Anteotech Ltd Ongoing Clinical Trials by Trial Status
- Anteotech Ltd Ongoing Clinical Trials Summary
- AtomoRapid - Heart Attack - Product Status
- AtomoRapid - Heart Attack - Product Description
- COVID-19 Antigen Flu A Flu B Multiplex RDT - Product Status
- COVID-19 Antigen Flu A Flu B Multiplex RDT - Product Description
- COVID-19 Flu A/ Flu B Multiplex Test - Product Status
- COVID-19 Flu A/ Flu B Multiplex Test - Product Description
- COVID-19 High Sensitivity Antigen Rapid Test - Product Status
- COVID-19 High Sensitivity Antigen Rapid Test - Product Description
- COVID-19 Saliva Test - Product Status
- COVID-19 Saliva Test - Product Description
- EuGeni COVID-19 Saliva Test - Product Status
- EuGeni COVID-19 Saliva Test - Product Description
- EuGeni Rapid Diagnostic System - Product Status
- EuGeni Rapid Diagnostic System - Product Description
- Point Of Care Tropical Disease Assay - Product Status
- Point Of Care Tropical Disease Assay - Product Description
- Point-Of-Care Bone Metabolism Assay - Product Status
- Point-Of-Care Bone Metabolism Assay - Product Description
- Point-of-Care Infectious Disease Assay - Product Status
- Point-of-Care Infectious Disease Assay - Product Description
- SARS-CoV-2 Ag Rapid Diagnostic Test (RDT) - Product Status
- SARS-CoV-2 Ag Rapid Diagnostic Test (RDT) - Product Description
- SARS-CoV-2 Ag Rapid Diagnostic Test (RDT) - A Prospective Clinical Trial to Evaluate the Efficacy of COVID-19 Antigen Rapid Test (ART) in Covid-19 Patient Samples
- Sepsis Diagnostic Test - Product Status
- Sepsis Diagnostic Test - Product Description
- Sepsis Multiplex RDT - Product Status
- Sepsis Multiplex RDT - Product Description
- Anteotech Ltd, Key Employees
- Anteotech Ltd, Key Employee Biographies
- Anteotech Ltd, Subsidiaries
- Glossary
- Anteotech Ltd Pipeline Products by Equipment Type
- Anteotech Ltd Pipeline Products by Development Stage
- Anteotech Ltd Ongoing Clinical Trials by Trial Status
Samples
LOADING...
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Pacific Edge Ltd
- Accelerate Diagnostics Inc
- Genera Biosystems Ltd
- Oxford Nanopore Technologies Plc
- SurModics Inc
- Bio-Rad Laboratories Inc
- Meridian Bioscience Inc
- Actinogen Medical Ltd
